Cancer-associated secondary lymphoedema
- 28 March 2019
- journal article
- research article
- Published by Springer Nature in Nature Reviews Disease Primers
- Vol. 5 (1) , 22
Abstract
Lymphoedema is an oedematous condition with a specific and complex tissue biology. In the clinical context of cancer, the pathogenesis of lymphoedema ensues most typically from the modalities employed to stage and treat the cancer (in particular, surgery and radiotherapy). Despite advances in cancer treatment, lifelong lymphoedema (limb swelling and the accompanying chronic inflammatory processes) affects approximately one in seven individuals treated for cancer, although estimates of lymphoedema prevalence following cancer treatment vary widely depending upon the diagnostic criteria used and the duration of follow-up. The natural history of cancer-associated lymphoedema is defined by increasing limb girth, fibrosis, inflammation, abnormal fat deposition and eventual marked cutaneous pathology, which also increases the risk of recurrent skin infections. Lymphoedema can substantially affect the daily quality of life of patients, as, in addition to aesthetic concerns, it can cause discomfort and affect the ability to carry out daily tasks. Clinical diagnosis is dependent on comparison of the affected region with the equivalent region on the unaffected side and, if available, with pre-surgical measurements. Surveillance is indicated in this high-risk population to facilitate disease detection at the early stages, when therapeutic interventions are most effective. Treatment modalities include conservative physical strategies that feature complex decongestive therapy (including compression garments) and intermittent pneumatic compression, as well as an emerging spectrum of surgical interventions, including liposuction for late-stage disease. The future application of pharmacological and microsurgical therapeutics for cancer-associated lymphoedema holds great promise.Keywords
This publication has 179 references indexed in Scilit:
- Lymphatic and Angiogenic Candidate Genes Predict the Development of Secondary Lymphedema following Breast Cancer SurgeryPLOS ONE, 2013
- Effects of manual lymphatic drainage on breast cancer-related lymphedema: a systematic review and meta-analysis of randomized controlled trialsWorld Journal of Surgical Oncology, 2013
- Therapeutic Lymphangiogenesis With Implantation of Adipose‐Derived Regenerative CellsJournal of the American Heart Association, 2012
- A randomized controlled trial comparing two types of pneumatic compression for breast cancer-related lymphedema treatment in the homeSupportive Care in Cancer, 2012
- Possible Genetic Predisposition to Lymphedema after Breast CancerLymphatic Research and Biology, 2012
- Assessment of Lymphatic Contractile Function After Manual Lymphatic Drainage Using Near-Infrared Fluorescence ImagingArchives of Physical Medicine and Rehabilitation, 2011
- Standardized Method for Quantification of Developing Lymphedema in Patients Treated for Breast CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studiesThe Lancet Oncology, 2011
- The Psycho-Social Impact of LymphedemaLymphatic Research and Biology, 2009
- Lymphedema in Breast Cancer Survivors: Incidence, Degree, Time Course, Treatment, and SymptomsJournal of Clinical Oncology, 2009